Richard J. Tajak
Direttore Finanziario/CFO presso Fresenius Kabi Pharmaceuticals Holding LLC
Profilo
Richard J.
Tajak is currently the EVP, Chief Financial & Accounting Officer at Fresenius Kabi Pharmaceuticals Holding LLC since 2011 and the Chief Financial & Operating Officer at NantPharma LLC since 2014.
Previously, he served as the Chief Financial Officer at NantKwest, Inc. from 2016 to 2018.
He also held positions as the Chief Financial Officer & Executive Vice President at APP Pharmaceuticals, Inc. and as the Senior Vice President-North American Finance at Astellas Pharmaceuticals SA. Mr. Tajak completed his undergraduate degree and MBA from the University of Notre Dame.
Posizioni attive di Richard J. Tajak
Società | Posizione | Inizio |
---|---|---|
Fresenius Kabi Pharmaceuticals Holding LLC
Fresenius Kabi Pharmaceuticals Holding LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi Pharmaceuticals Holding LLC is a pharmaceutical company, which engages in the development, manufacturing, and marketing of injectable pharmaceutical products. It primarily focuses on the injectable oncology, anti-infective, anesthetic/analgesic, and critical care markets. The firm manufactures products in each of the three basic forms, which include liquid, powder, and lyophilized or freeze-dried. Its products are generally used in hospitals, long-term care facilities, alternate care sites and clinics. The company was founded on July 2, 2008 and is headquartered in Wilmington, DE. | Direttore Finanziario/CFO | 28/02/2011 |
NantPharma LLC
NantPharma LLC Pharmaceuticals: MajorHealth Technology Part of NantWorks LLC, NantPharma LLC is a company that manufactures injectable pharmaceutical products. The company is based in Lincolnshire, IL. | Direttore Finanziario/CFO | 01/01/2014 |
Precedenti posizioni note di Richard J. Tajak
Società | Posizione | Fine |
---|---|---|
IMMUNITYBIO, INC. | Direttore Finanziario/CFO | 11/06/2018 |
Astellas Pharmaceuticals SA | Corporate Officer/Principal | - |
APP Pharmaceuticals, Inc.
APP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology APP Pharmaceuticals, Inc. develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. It offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations. The company is headquartered in Los Angeles, CA. | Direttore Finanziario/CFO | - |
Formazione di Richard J. Tajak
University of Notre Dame | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 5 |
---|---|
NantKwest, Inc.
NantKwest, Inc. BiotechnologyHealth Technology NantKwest, Inc. engages in the research and development of immunotherapies. It uses natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. The company was founded by Gary N. Keller and Hans Georg Klingemannon October 7, 2002 and is headquartered in San Diego, CA. | Health Technology |
APP Pharmaceuticals, Inc.
APP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology APP Pharmaceuticals, Inc. develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. It offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations. The company is headquartered in Los Angeles, CA. | Health Technology |
Fresenius Kabi Pharmaceuticals Holding LLC
Fresenius Kabi Pharmaceuticals Holding LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi Pharmaceuticals Holding LLC is a pharmaceutical company, which engages in the development, manufacturing, and marketing of injectable pharmaceutical products. It primarily focuses on the injectable oncology, anti-infective, anesthetic/analgesic, and critical care markets. The firm manufactures products in each of the three basic forms, which include liquid, powder, and lyophilized or freeze-dried. Its products are generally used in hospitals, long-term care facilities, alternate care sites and clinics. The company was founded on July 2, 2008 and is headquartered in Wilmington, DE. | Health Technology |
Astellas Pharmaceuticals SA | |
NantPharma LLC
NantPharma LLC Pharmaceuticals: MajorHealth Technology Part of NantWorks LLC, NantPharma LLC is a company that manufactures injectable pharmaceutical products. The company is based in Lincolnshire, IL. | Health Technology |
- Borsa valori
- Insiders
- Richard J. Tajak